These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 483271)

  • 1. Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy.
    Barlow GH; Kakkar VV; Bentley PG; Chan PS; Jones NA; Mistry FD
    Thromb Res; 1979; 15(1-2):135-42. PubMed ID: 483271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 3. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermittent plasminogen-streptokinase treatment of deep vein thrombosis.
    Scully MF; Lane DA; Sagar S; Thomas DP; Kakkar VV
    Thromb Haemost; 1977 Feb; 37(1):162-9. PubMed ID: 138963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical changes noted during intermittent administration of streptokinase.
    Verstraete M; Vermylen J; Schetz J
    Thromb Haemost; 1978 Feb; 39(1):61-8. PubMed ID: 148118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.
    Smith RA; Dupe RJ; English PD; Green J
    Nature; 1981 Apr; 290(5806):505-8. PubMed ID: 7219537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
    Jude B; Amrouni N; Deguine I; Marey A; Asseman P; Watel A; Thery C; Marache P; Cosson A
    Thromb Res; 1992 Feb; 65(3):457-62. PubMed ID: 1631808
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of plasminogen activator to fibrin.
    Chesterman CN; Allington MJ; Sharp AA
    Nat New Biol; 1972 Jul; 238(79):15-7. PubMed ID: 18663837
    [No Abstract]   [Full Text] [Related]  

  • 12. Acyl enzymes for thrombolytic therapy.
    Walker ID; Davidson JF
    Semin Thromb Hemost; 1987 Apr; 13(2):139-45. PubMed ID: 3306926
    [No Abstract]   [Full Text] [Related]  

  • 13. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the streptokinase-induced activation of human plasminogen by human fibrinogen and human fibrinogen fragment D1.
    Castellino FJ; Strickland DK; Morris JP; Smith J; Chibber B
    Ann N Y Acad Sci; 1983 Jun; 408():595-601. PubMed ID: 6575703
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha 2-plasmin inhibitor deficiency.
    Lipinski B; Gurewich V
    Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of deep venous thromboses using a plasminogen-streptokinase sequence. Preliminary study].
    Kakkar VV; Toulemonde F
    Nouv Presse Med; 1976 Apr; 5(15):981-3. PubMed ID: 778784
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.
    Fears R; Hibbs MJ; Smith RA
    Biochem J; 1985 Jul; 229(2):555-8. PubMed ID: 4041182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin.
    Brosstad F
    Thromb Res; 1979; 15(3-4):497-504. PubMed ID: 158847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.